Meperidine

CHEMBL607 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

247.3 g/mol

LogP

2.5

Phase

4

An opioid analgesic used for the short-term relief of moderate-to-severe pain, often used before or during medical procedures or for acute pain management. Due to its toxic metabolite normeperidine, it is generally not recommended for prolonged use.

Masse moléculaire

247,3300 g/mol

LogP

2,50

TPSA

29,50 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pancreatic Cancer Pain Management Non-Small Cell Lung Cancer Generalized Anxiety Disorder Stroke Obesity Breast Cancer Chronic Pain Hepatitis C

Mécanisme d'action

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOC(=O)C1(c2ccccc2)CCN(C)CC1

InChI

InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3

Molecular Formula

C15H21NO2

HBD / HBA

- / 3

Liaisons Rotatives

4

Atomes Lourds

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

An opioid analgesic used for the short-term relief of moderate-to-severe pain, often used before or during medical procedures or for acute pain management. Due to its toxic metabolite normeperidine, it is generally not recommended for prolonged use.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Meperidine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL607. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4058. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Meperidine sur PillFYI

Structure

Données Clés

Formule: C15H21NO2
Synonymes: 3

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.